An in-depth look to NOVONESIS (NOVOZYMES) B operating, investing, and financing activities

NSIS/N free cash flow for H1 24 is 7.7 B MXN. For 2023, NSIS/N free cash flow was 5.77 B MXN and operating cash flow was 10.44 B MXN.